Antifungals represent a critical class of medications designed to combat fungal infections, offering relief from ailments caused by a diverse array of fungi. Azoles, such as fluconazole, interfere with fungal cell membrane synthesis, disrupting their structural integrity and impeding growth. Polyenes, like amphotericin B, bind to fungal cell membranes, causing membrane leakage and eventual cell death. Echinocandins, a newer class, inhibit the synthesis of fungal cell walls, curbing the progression of invasive fungal infections. Antifungals find applications in treating common conditions like athlete's foot and yeast infections, as well as more severe systemic infections such as candidiasis and aspergillosis. However, challenges persist, including the emergence of antifungal resistance, particularly in immunocompromised individuals. Ongoing research strives to unravel new antifungal targets and develop innovative strategies to address the dynamic landscape of fungal infections.
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change and increasing death due to resistant infection
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Recurrent klebsiella pneumoniae pyogenic liver abscess: Developing a literature-informed 0–2 scoring framework from a solved index case
Martha Grace McLean, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Post-hysterectomy pelvic abscess mimic: An AI-assisted diagnostic stewardship workflow
Setu Shiroya, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Building a clinical reasoning tool from post-transplant MRSA sepsis: A mentored ai workflow
Michaela Mitchell, Anne Burnett Marion School of Medicine at Texas Christian University, United States